SCHEMBL24124182

SCHEMBL24124182

CCN(c1ccccc1)[S+]([O-])c1cccc(NC(=O)c2ccc(S)c(N)c2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNK3 O14649 4/20 0.40
▸ KMT2A Q03164 7/20 0.40
▸ MEN1 O00255 6/20 0.40
▸ SMN1; SMN2 Q16637 5/20 0.40
▸ MAPT P10636 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ HTT P42858 3/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ MAPK1 P28482 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ KCNK9 Q9NPC2 4/20 0.38
▸ BCHE P06276 2/20 0.38
▸ POLB P06746 2/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ NR1H4 Q96RI1 1/20 0.37
▸ F2R P25116 1/20 0.36
▸ NFKB1 P19838 1/20 0.36
▸ NFKB2 Q00653 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24124174 0.87 KCNK3 (0.45) KCNK3KMT2AMEN1SMN1; SMN2MAPT
SCHEMBL24124178 0.75 HDAC3 (0.54) KCNK3KMT2AMEN1POLBNR1H4
SCHEMBL24124923 0.74 KMT2A (0.51) KCNK3KMT2AMEN1HTTNPC1
SCHEMBL24124948 0.72 HDAC1 (0.44) KMT2AMEN1MAPTLMNANPC1
SCHEMBL24124189 0.71 HDAC8 (0.54) KCNK3KMT2AKCNK9NR1H4
SCHEMBL24124180 0.68 NR1H4 (0.68) KMT2AMEN1SMN1; SMN2MAPTLMNA
SCHEMBL24124921 0.68 KMT2A (0.50) KCNK3KMT2AMEN1SMN1; SMN2MAPT
SCHEMBL24124876 0.66 GPR27 (0.67) KMT2AMEN1SMN1; SMN2MAPTALDH1A1
SCHEMBL6813579 0.66 HDAC2 (0.56) KCNK3KMT2AMEN1SMN1; SMN2NPC1
SCHEMBL24124210 0.65 HDAC3 (0.46) KMT2AMEN1MAPTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021257544-A1 SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2021-12-23 — — WO disclosed
Send feedback